Completed PHASE3 INTERVENTIONAL NCT00407394

Indiaclen Short Course Amoxycillin Therapy for Pneumonia With Wheeze

Randomized Double Blind Placebo Controlled Trial of Amoxycillin in the Treatment of Non-Severe Pneumonia With Wheeze in Children Aged 2- 59 Months of Age: A Multi-Centric Study

Sponsor: King George's Medical University

Conditions Non-Severe Pneumonia With Wheeze

Interventions Amoxycillin

Updated 4 times since 2017 Last updated: Dec 2, 2006 Started: Apr 30, 2004 Completion: Apr 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Non-Severe Pneumonia With Wheeze and is currently completed. King George's Medical University leads this study, which shows 4 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2017 — Jan 2021 [monthly]

Completed PHASE3

First recorded

Apr 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

King George's Medical University
United States Agency for International Development (USAID)

Data source: King George's Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lucknow, India